Clover Health (CLOV) | Stock Overview & Key Data
Clover Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $28.85 on June 7, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Clover Health
CLOV
|
1.26B Small-cap | 22.70% | 38.62% | 144.16% | 83.59% | 99.59% | 64.24% | 425.56% | -60.71% | -53.63% | -53.63% | -53.63% |
|
UnitedHealth
UNH
|
322.34B Mega-cap | 1.10% | 4.36% | 43.98% | 20.50% | 22.19% | 30.30% | -10.90% | 4.92% | 196.70% | 717.69% | 822.38% |
|
CVS Health
CVS
|
101.07B Large-cap | 3.71% | 5.00% | 32.75% | 26.34% | 25.65% | 51.14% | 50.56% | 23.74% | 7.51% | 173.13% | 237.73% |
|
Progyny
PGNY
|
1.45B Small-cap | 3.82% | 15.74% | 54.48% | 2.16% | 4.55% | 26.63% | -31.61% | -58.69% | 67.06% | 67.06% | 67.06% |
|
Elevance Health
ELV
|
76.43B Large-cap | -3.89% | 2.35% | 37.60% | 11.43% | 13.45% | 5.08% | -8.83% | 9.44% | 205.33% | 430.00% | 468.71% |
|
Cigna
CI
|
72.68B Large-cap | 1.46% | 3.00% | 9.50% | 6.02% | 5.27% | -6.11% | 10.85% | 28.46% | 130.12% | 509.53% | 856.66% |
Ownership & Short Interest
Calculate Your Clover Health Investment Returns
Long-Term Investment Performance Analysis
Clover Health stock price in Jun 2020 was $10.20, A $1,000.00 lump sum investment in Clover Health made 6 years ago would be worth approximately $471.57 today, representing a negative return of -52.84%. This translates to an annualized return (CAGR) of -11.74%.
6 Years Investment Scenario (Jun 2020 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CLOV's 52-week high and low?
- In the last 52 weeks, Clover Health reached a high of $5.18 (on June 11, 2026) and a low of $1.58 (on April 1, 2026).
- What is the market cap and P/E ratio for CLOV?
- Curious about Clover Health's size and valuation? Its market capitalization stands at 1.26B. When it comes to valuation, the P/E ratio (trailing twelve months) is -14.09, and the forward P/E (looking ahead) is 27.78.
- Does CLOV pay dividends? If so, what's the yield?
- As for dividends, Clover Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Clover Health's main competitors or similar companies to consider before investing?
When looking at Clover Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UnitedHealth
UNH322.34B Healthcare Healthcare Plans 30.30% -10.90% CVS Health
CVS101.07B Healthcare Healthcare Plans 51.14% 50.56% Progyny
PGNY1.45B Healthcare Healthcare Plans 26.63% -31.61% Elevance Health
ELV76.43B Healthcare Healthcare Plans 5.08% -8.83% Cigna
CI72.68B Healthcare Healthcare Plans -6.11% 10.85% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Clover Health Investments Corp.? (e.g., ROE, Debt/Equity)
- To get a sense of Clover Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -26.33%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 15.22%.
- What is the recent revenue and earnings growth for CLOV?
- Looking at Clover Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 44.70%, and quarterly earnings saw a YoY growth of 44.74%.
- How much of CLOV stock is held by insiders and institutions?
- Wondering who owns Clover Health stock? Company insiders (like executives and directors) hold about 3.25% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 29.71%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.